Does SETMELANOTIDE Cause Decreased appetite? 19 Reports in FDA Database
Lose Weight Fast — The 21-Day Smoothie Diet
36 fat-burning recipes + shopping lists. Results in the first week.
According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Decreased appetite have been filed in association with SETMELANOTIDE (Imcivree). This represents 10.4% of all adverse event reports for SETMELANOTIDE.
19
Reports of Decreased appetite with SETMELANOTIDE
10.4%
of all SETMELANOTIDE reports
0
Deaths
11
Hospitalizations
How Dangerous Is Decreased appetite From SETMELANOTIDE?
Of the 19 reports, 11 (57.9%) required hospitalization.
Is Decreased appetite Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SETMELANOTIDE. However, 19 reports have been filed with the FAERS database.
What Other Side Effects Does SETMELANOTIDE Cause?
Nausea (53)
Off label use (48)
Skin hyperpigmentation (43)
Headache (27)
Skin discolouration (26)
Diarrhoea (24)
Vomiting (24)
Fatigue (23)
Injection site pruritus (19)
Injection site erythema (17)
What Other Drugs Cause Decreased appetite?
ADALIMUMAB (6,135)
LENALIDOMIDE (5,103)
SEMAGLUTIDE (4,317)
METHOTREXATE (4,229)
CABOZANTINIB S-MALATE (4,076)
APREMILAST (3,442)
RITUXIMAB (3,438)
PALBOCICLIB (3,400)
PREDNISONE (3,390)
LENVATINIB (3,257)
Which SETMELANOTIDE Alternatives Have Lower Decreased appetite Risk?
SETMELANOTIDE vs SEVELAMER
SETMELANOTIDE vs SEVOFLURANE
SETMELANOTIDE vs SIBUTRAMINE
SETMELANOTIDE vs SILDENAFIL
SETMELANOTIDE vs SILODOSIN